NRX Pharmaceuticals Inc (NASDAQ:NRXP)

5.96
Delayed Data
As of Dec 06
 +0.455 / +8.27%
Today’s Change
4.07
Today|||52-Week Range
76.99
-75.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$388.1M

Company Description

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Contact Information

NRX Pharmaceuticals, Inc.
1201 Orange Street
Wilmington Delaware 19801
P:(484) 254-6134
Investor Relations:

Employees

Shareholders

Individual stakeholders30.17%
Mutual fund holders2.04%
Other institutional1.24%

Top Executives

Jonathan C. JavittChairman & Chief Executive Officer
Robert BesthofChief Commercial & Patent Officer, Head-Operations
James BrandonChief Financial Officer
Dennis K. McBrideChief Strategy Officer
Randy GuggenheimerChief Business Officer